GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy, was approved for treatment of epilepsy in 2018.
If you currently work at this organization, click the “Do you work here?” button to request editing privileges.
This SponsorPitch page is about GW Pharmaceuticals and contains information about this organization's sponsorship activity, sponsorship decision makers and sponsorship preferences. This page is not endorsed by or affiliated with GW Pharmaceuticals , though it may be actively managed and updated by company representatives. If you currently work at this organization, click the Manage Sponsor button to request management privileges. . All trademarks, service marks and copyrights are property of their respective owners.
Please log in to access this feature. Don't have an account? Sign up today!